Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger

Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger

The purpose of this proposed study is to assess effectiveness of MOHS micrographic surgery as a form of treatment for dermatofibrosarcoma protuberans in patients who are 10 years of age or younger through review of the patients at Mayo Clinic treated from 1988-2017, and to explore the challenges that providers face which may prevent them performing this potentially superior treatment. This study will provide a comparison of outcomes and recurrence rates in pediatric patients treated by MOHS versus traditional excision.

Must be 10 years of age or younger. Must have biopsy proven dermatofibrosarcoma protuberans.